Xaliproden (codenamed SR57746) is a drug which has been proposed for use in the treatment of Alzheimer's disease.
2 edits since May 19, 2008. Last edited Jul 15, 2008 by Carlo Banez (49).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Xaliproden. See this site's terms for details.